Rainbow Childrens Medicare / Q3-FY26

RAINBOW Q3 FY26 earnings call.

A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Watch2026-02-03Back to RAINBOW

Revenue

₹445.4 Cr

verified against source

Revenue YoY

12%

reported change

EBITDA

₹147 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
EBITDA (₹ Cr)PositiveWatchNegative
2 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q2 FY26: 149 · Watch source sentiment · 2025-10-15Q2 FY26Q3 FY26: 147 · Watch source sentiment · 2026-02-03Q3 FY26149147
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Rainbow Children's Medicare reported Q3 FY26 revenue of ₹445.4 crore (+12% YoY), EBITDA of ₹147 crore (+9%) at 33% margin, and PAT of ₹73.9 crore (+7.2%). Growth was below expectations due to seasonally muted Q3—particularly impacting mature clusters in Hyderabad, Bangalore, and Vijayawada—where outpatient footfalls and admissions underperformed. New units at Rajnandri (100 beds) are near break-even within months, while the 90-bed Electronic City facility and upcoming Huskur hospital (60 beds) will drive volume ramp. The company guided to 55%+ occupancy next year through strengthened sales & marketing, digital initiatives, and clinic expansions. International revenue fell to ~2% due to geopolitical disruptions (Bangladesh, Sudan, Somalia), though management targets a return to 18% CAGR over a 4-year horizon. Guwahati acquisition is performing well with cardiac program planned for mid-year. The stock faces near-term pressure from below-50% occupancy and single-digit organic growth, offset by strong cash position of ₹579 crore and reduced capex requirements.

Colored figures show movement against the previous available record.

Guidance to track

  • Management committed to achieving north of 55% occupancy driven by strengthened sales & marketing, digital initiatives, and aggressive clinic expansion to reduce dependence on seasonal admissions.
  • On a 4-year CAGR basis (excluding FY26), management reiterated 18% revenue growth target, positioning this as the 'safe zone' for Rainbow given historical performance.
  • The 60-bed Huskur hospital in Bangalore is in final government approval stages and expected to commence operations within weeks, targeting break-even within 12 months.
  • The 130-bed regional hub in Gurgaon (Sector 44/56) is at basement slab stage with completion targeted by end of FY27, positioned to capture NCR pediatric market.

Risks flagged

  • Multiple multi-specialty hospitals in Hyderabad are aggressively building mother-and-child services, competing for outpatient footfalls and deliveries. Management acknowledged 'no doubt' competition is increasing and requires active response through local clinic expansions.
  • Management admitted uncertainty whether Q4 FY25 and Q1-Q3 FY26 weakness reflects a structural shift or temporary pattern. The CEO noted 'seasonality is one factor' and the company is restructuring to reduce dependence on seasonal volumes, but success is not guaranteed.
  • International patient revenue declined to ~2% from budgeted 4% due to disruptions in Bangladesh, Sudan, Somalia, and Somalia travel bans. Bangladesh specifically flagged as 'really challenging now' with no near-term resolution apparent.
  • Only 85 of 150 licensed beds operational in Guwahati. Expansion to full capacity planned over '3-4 months' but no firm timeline commitment given. Cardiac program launch targeted for 'mid-year' remains vague.

Key quotes

  • We are somewhere around 30-40 [on a scale of 1-100 for digital/marketing capabilities]. I wouldn't rate myself more than that. Rainbow is always grown as a kind of very organic, very doctor-driven, very community inclusive... cities are becoming very very fragmented and people rather than asking for opinion about neighborhood they go to the digital platforms—that is the world we are in.
  • When you have a seasonal business proportionate to the IQT business and also the large intensive care business it will not impact much. When you have a seasonal business which are simple illnesses occupying one bed days, two bed days—definitely it will lower [ARPOB] because you got lots and lots of children getting admitted for one day and two days where the billing is very small.
  • The middle one [construction phase] is in our hands. The first [planning approvals] and last one [government permissions] is I think we have to depend on the local government and the policies... sometimes the elections comes in the local body elections they will take away four five months time. So you can't do anything about it.

Research modules

Go one layer deeper.